Brief observations on the management of Wilson's disease.
D002614:Chelating Agents / Q000627:therapeutic use; D006527:Hepatolenticular Degeneration / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D010396:Penicillamine / Q000009:adverse effects / Q000627:therapeutic use*; D011736:Pyridoxine / Q000378:metabolism
D002614:Chelating Agents; D010396:Penicillamine; D011736:Pyridoxine